These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 18784387

  • 1. [The use of recombinant activated factor VIIa for major bleedings in open heart surgery].
    Ingimarsson JP, Onundarson PT, Valsson F, Vidarsson B, Gudbjartsson T.
    Laeknabladid; 2008 Sep; 94(9):607-12. PubMed ID: 18784387
    [Abstract] [Full Text] [Related]

  • 2. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
    Tatoulis J, Theodore S, Meswani M, Wynne R, Hon-Yap C, Powar N.
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
    [Abstract] [Full Text] [Related]

  • 3. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [Abstract] [Full Text] [Related]

  • 4. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.
    J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579
    [Abstract] [Full Text] [Related]

  • 5. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
    Chapman AJ, Blount AL, Davis AT, Hooker RL.
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
    [Abstract] [Full Text] [Related]

  • 6. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F, Castillo JG, Rahmanian PB, Scurlock C, Fischer G, Adams DH.
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [Abstract] [Full Text] [Related]

  • 7. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H, Dagan O.
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [Abstract] [Full Text] [Related]

  • 8. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [Abstract] [Full Text] [Related]

  • 9. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
    Feih JT, Juul JJ, G Rinka JR, Baumann Kreuziger LM, Pagel PS, Tawil JN.
    Ann Card Anaesth; 2019 Apr; 22(4):388-393. PubMed ID: 31621674
    [Abstract] [Full Text] [Related]

  • 10. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK, Lobato RL, Bartlett B, Klanjac M, Mora-Mangano CT, Soran PD, Oakes DA, Hill CC, van der Starre PJ.
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [Abstract] [Full Text] [Related]

  • 11. Characteristics Associated With Mortality in 372 Patients Receiving Low-Dose Recombinant Factor VIIa (rFVIIa) for Cardiac Surgical Bleeding.
    Baral P, Cotter E, Gao G, He J, Wirtz K, Sharma A, Zorn Iii T, Muehlebach G, Flynn B.
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2133-2140. PubMed ID: 30772178
    [Abstract] [Full Text] [Related]

  • 12. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
    Guzzetta NA, Huch S, Fernandez JD, Tosone SR, Miller BE.
    Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
    [Abstract] [Full Text] [Related]

  • 15. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
    Okonta KE, Edwin F, Falase B.
    Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):690-4. PubMed ID: 22811512
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Efficacy of recombinant activated factor VII for massive bleeding after cardiac surgery: experience with 32 patients].
    Millán C, Quintana B, Rodríguez A, Iglesias M, Barranco M, Navia J.
    Rev Esp Anestesiol Reanim; 2009 Oct; 56(8):485-92. PubMed ID: 19994617
    [Abstract] [Full Text] [Related]

  • 18. Recombinant factor VIIa as last-resort treatment of desperate haemorrhage.
    Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.
    Acta Anaesthesiol Scand; 2012 May; 56(5):636-44. PubMed ID: 22489992
    [Abstract] [Full Text] [Related]

  • 19. Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation.
    Hollis AL, Lowery AV, Pajoumand M, Pham SM, Slejko JF, Tanaka KA, Mazzeffi M.
    Ann Card Anaesth; 2016 May; 19(3):418-24. PubMed ID: 27397445
    [Abstract] [Full Text] [Related]

  • 20. Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.
    von Heymann C, Redlich U, Jain U, Kastrup M, Schroeder T, Sander M, Grosse J, Ziemer S, Koscielny J, Konertz WF, Wernecke KD, Spies C.
    Crit Care Med; 2005 Oct; 33(10):2241-6. PubMed ID: 16215377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.